Liver Fibrosis Regression and Associated Factors in HCV Patients Treated with Direct-Acting Antiviral Agents

There is accumulating evidence that treatment of chronic hepatitis C (HCV) leads to improvements in liver fibrosis. We aimed to investigate the improvement in fibrosis stage following treatment with direct-acting antivirals (DAAs) and factors associated with fibrosis regression. Fibroscan(®) was per...

Descripción completa

Detalles Bibliográficos
Autores principales: Abu-Freha, Naim, Abu-Kosh, Osama, Yardeni, David, Ashur, Yaffa, Abu-Arar, Muhammad, Yousef, Baha, Monitin, Shulamit, Weissmann, Sarah, Etzion, Ohad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10533124/
https://www.ncbi.nlm.nih.gov/pubmed/37763276
http://dx.doi.org/10.3390/life13091872

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10533124/
https://www.ncbi.nlm.nih.gov/pubmed/37763276
http://dx.doi.org/10.3390/life13091872

Ejemplares similares